“…Some other proteins found overabundant in the in vivo -derived embryos were previously identified as interacting with in vitro -produced embryos after incubation with post-ovulatory oviduct fluid, including retinal dehydrogenase 1 (ALDH1A1) and alpha isoform of regulatory subunit A protein phosphatase 2 (PPP2R1A) at the 4–6 cell stage, cytoplasmic aconitate hydratase (ACO1), hemoglobin subunit beta (HBB) and purine nucleoside phosphorylase (PNP) at the morula stage, and annexin A8 (ANXA8), creatine kinase B-type (CKB), chloride intracellular channel protein 1 (CLIC1), cytosolic non-specific dipeptidase (CNDP2), hemoglobin subunit alpha (HBA), ribonuclease inhibitor (RNH1), tubulin polymerization-promoting protein family member 3 (TPPP3), and CD109 at both stages [ 25 ]. A comparison between proteins in cluster 1 and those identified by MS in the isthmic part of the oviduct fluid just after ovulation [ 59 ], i.e., place and time of early embryo development, indicates that 341 (75%) are also present in the oviduct fluid (data not shown). Among those, OVGP1, CD109, CLU, RARRES1, and tubulin beta-4B chain (TUBB4B) were quantified at high abundance in the postovulatory oviduct fluid (36 to 121 NWS, [ 59 ]) and were found overabundant in in vivo -derived embryos from the 4–6 cell up to blastocyst stages, making them good candidates for embryo-interacting proteins originated in the oviduct.…”